Skip to content
GLP-1 Scorecard
Menu
Graded #53

Hims & Hers

Mass-market app-first program with nationwide reach and consumer-grade polish.

Visit Hims & HersWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$199/mo
Tirzepatide
Not disclosed
Coverage
All 50 states
Brand-name
Compounded only

Weigh Hims & Hers against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Hims & Hers dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value82/100
Dose & formulation78/100
Clinical oversight55/100
Labs & monitoring80/100
Fulfillment84/100
Contract terms80/100

Strengths

  • Nationwide
  • Polished app
  • Strong brand trust

Where it loses points

  • Tirzepatide pricing inconsistently disclosed
  • Industry-wide compounding scrutiny

Bottom line — Grade C

Best for: People who want a familiar, app-driven consumer brand.

Ranked #53 of 508 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.

Closest on the board

The boards grading nearest Hims & Hers — the realistic shortlist.

The 22 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Hims & Hers's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Hims & Hers's site. Not medical advice; see our disclosure.

← Back to the scorecard